Vaccines Alone Are Not Enough to Beat COVID

President Biden’s current executive order calling for more massive randomized scientific trials and further research studies on the most promising treatments to date. Federal government oversight is needed to effectively examine the threats and advantages of existing EUA treatments separately and in mix because frequently these drugs are used together.

Assistance is likewise needed for using other available FDA-approved off-the-shelf drugs that may assist avoid hospitalizations, as in the recent findings indicating colchicine, a common gout medication, avoids COVID-19 hospitalizations. At the Feinstein Institutes, we are also studying the usage of famotidine, the typical antacid Pepcid, in outpatients to examine whether it might likewise lower the need for hospitalization.

President Biden need to also arrange an advisory panel to collaborate these scientific trial efforts and share outcomes from outcomes and finest practices. Since it is in the interest of national security, such coordination and prioritization of clinical trials can not be left to the profit-driven pharmaceutical industry.

Not surprisingly and appropriately enough, it is a nationwide top priority to immunize the population. Not at the expenditure of overlooking patients who will continue to end up being ill and require new lifesaving treatments.